Morgan Stanley
ALIM

Morgan Stanley’s Alimera Sciences ALIM Stock Holding History

Morgan Stanley’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-515,304
Closed -$2.87M – 8077
2024
Q2 		$2.87M Buy
515,304
+13,566
+3% +$48.2K ﹤0.01% 4323
2024
Q1 		$1.96M Sell
501,738
-1,330,754
-73% -$5.07M ﹤0.01% 4593
2023
Q4 		$7.92M Buy
1,832,492
+1,166,246
+175% +$3.94M ﹤0.01% 4091
2023
Q3 		$2.07M Hold
666,246
– – ﹤0.01% 4373
2023
Q2 		$1.95M Hold
666,246
– – ﹤0.01% 4439
2023
Q1 		$1.4M Hold
666,246
– – ﹤0.01% 4669
2022
Q4 		$1.81M Sell
666,246
-3,300
-0.5% -$14K ﹤0.01% 4525
2022
Q3 		$3.4M Buy
669,546
+106,222
+19% +$647K ﹤0.01% 4000
2022
Q2 		$3.08M Hold
563,324
– – ﹤0.01% 4177
2022
Q1 		$3.15M Buy
563,324
+133,778
+31% +$651K ﹤0.01% 4154
2021
Q4 		$2.2M Hold
429,546
– – ﹤0.01% 4510
2021
Q3 		$1.81M Buy
429,546
+1,437
+0.3% +$10K ﹤0.01% 4651
2021
Q2 		$3.9M Buy
428,109
+2,797
+0.7% +$27.5K ﹤0.01% 4040
2021
Q1 		$4.09M Buy
425,312
+4,600
+1% +$37.7K ﹤0.01% 3617
2020
Q4 		$1.78M Buy
420,712
+415,972
+8,776% +$1.86M ﹤0.01% 4255
2020
Q3 		$23K Hold
4,740
– – ﹤0.01% 6014
2020
Q2 		$30K Sell
4,740
-5,827
-55% -$30.4K ﹤0.01% 5878
2020
Q1 		$42K Buy
10,567
+242
+2% +$1.47K ﹤0.01% 5537
2019
Q4 		$78K Sell
10,325
-67,275
-87% -$402K ﹤0.01% 5732
2019
Q3 		$659K Buy
77,600
+10
+0% +$91 ﹤0.01% 4542
2019
Q2 		$1.03M Sell
77,590
-11
-0% -$155 ﹤0.01% 4201
2019
Q1 		$1.23M Sell
77,601
-26
-0% -$396 ﹤0.01% 3969
2018
Q4 		$836K Sell
77,627
-275
-0.4% -$4.01K ﹤0.01% 4410
2018
Q3 		$1.15M Buy
77,902
+2,414
+3% +$36.7K ﹤0.01% 4430
2018
Q2 		$1.11M Buy
75,488
+75,461
+279,485% +$1.06M ﹤0.01% 4560
2018
Q1 		$0 Hold
27
– – ﹤0.01% 6723
2017
Q4 		$1K Hold
27
– – ﹤0.01% 6518
2017
Q3 		$1K Hold
27
– – ﹤0.01% 6476
2017
Q2 		$1K Sell
27
-133
-83% -$2.85K ﹤0.01% 6530
2017
Q1 		$3K Buy
160
+133
+493% +$2.56K ﹤0.01% 6430
2016
Q4 		$0 Sell
27
-53
-66% -$970 ﹤0.01% 6578
2016
Q3 		$2K Sell
80
-587
-88% -$13.5K ﹤0.01% 6375
2016
Q2 		$12K Buy
667
+413
+163% +$11K ﹤0.01% 6016
2016
Q1 		$7K Sell
254
-116
-31% -$3.61K ﹤0.01% 6216
2015
Q4 		$14K Sell
370
-206
-36% -$8.94K ﹤0.01% 6151
2015
Q3 		$19K Sell
576
-706
-55% -$39.8K ﹤0.01% 6067
2015
Q2 		$89K Sell
1,282
-390
-23% -$26.9K ﹤0.01% 5643
2015
Q1 		$126K Buy
1,672
+105
+7% +$8.26K ﹤0.01% 5431
2014
Q4 		$130K Sell
1,567
-22,921
-94% -$1.86M ﹤0.01% 5432
2014
Q3 		$1.99M Sell
24,488
-487
-2% -$41.6K ﹤0.01% 3438
2014
Q2 		$2.24M Buy
24,975
+410
+2% +$36.4K ﹤0.01% 3400
2014
Q1 		$2.91M Buy
24,565
+24,044
+4,615% +$2.34M ﹤0.01% 3104
2013
Q4 		$37K Sell
521
-916
-64% -$37.3K ﹤0.01% 5704
2013
Q3 		$81K Sell
1,437
-735
-34% -$46.1K ﹤0.01% 5135
2013
Q2 		$159K Buy
+2,172
New +$125K ﹤0.01% 4935

Morgan Stanley's ALIM Position: Q3 2024 in Review

Morgan Stanley sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 515,304 shares — an estimated $2.87M sold.

Morgan Stanley first reported a position in ALIM in Q2 2013 and held it in 45 quarters. The position peaked at $7.92M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Morgan Stanley reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 515,304 Alimera Sciences shares in Q3 2024, an estimated $2.87M.
  • Morgan Stanley first reported a position in Alimera Sciences in Q2 2013 and held it in 45 quarters.
  • Morgan Stanley's Alimera Sciences position peaked at $7.92M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.